Trial Profile
A study to evaluate the effect of switching long-acting antipsychotic medication from fluphenazine decanoate to paliperidone palmitate in psychotic patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Psychotic disorders; Schizophrenia
- Focus Therapeutic Use
- 05 Nov 2016 New trial record
- 20 Sep 2016 Results presented at the 29th Annual Congress of the European College of Neuropsychopharmacology